wnt
protein
bind
seventransmembran
frizzl
receptor
mediat
import
development
morphogenet
tissueregen
effect
wnt
signal
dysregul
wnt
signal
associ
mani
cancer
current
exist
drug
candid
even
tool
compound
modul
wntmediat
receptor
traffick
subsequ
wnt
signal
examin
librari
fdaapprov
drug
util
frizzl
intern
modul
employ
primari
imagedbas
gfpfluoresc
assay
use
endocytosi
readout
report
antihelminth
niclosamid
drug
use
treatment
tapeworm
promot
endocytosi
regul
protein
inhibit
stabil
leftcf
report
activ
addit
follow
niclosamid
mediat
intern
receptor
coloc
vesicl
contain
transferrin
agonistactiv
adrenerg
receptor
therefor
niclosamid
may
serv
neg
modul
signal
deplet
upstream
signal
molecul
ie
frizzl
dishevel
moreov
may
provid
valuabl
mean
studi
physiolog
consequ
wnt
signal
import
inappropri
wnt
signal
lost
pharmaceut
industri
academia
consid
compon
wnt
signal
prime
drug
target
due
access
plasma
membran
receptor
like
frizzl
also
appeal
target
prescript
drug
howev
current
fdaapprov
drug
tool
compound
regul
wnt
signal
level
frizzl
receptor
address
need
institut
translat
small
molecul
screen
program
identifi
candid
lead
affect
frizzl
endocytosi
furthermor
expedit
develop
wntfrizzl
signal
modul
search
exist
librari
contain
fdaapprov
drug
discov
antihelminth
niclosamid
promot
intern
presenc
block
downstream
signal
plasmid
antibodi
condit
media
stock
stock
obtain
addgen
cambridg
report
plasmid
obtain
dr
randal
moon
plasmid
renilla
luciferas
purchas
promega
adrenerg
receptorrfp
arrfp
prepar
similarli
describ
gfp
deriv
lot
antibodi
obtain
santa
cruz
cell
line
produc
control
condit
media
obtain
atcc
condit
media
gener
grow
cell
dmem
plu
fb
accord
protocol
describ
http
assay
obtain
stabl
cell
line
cell
transfect
ratio
weight
use
nucleofect
transfect
protocol
amaxa
stabl
receptor
express
clone
select
use
puromycin
cultur
medium
gener
topflash
stabl
cell
line
cell
transfect
renilla
luciferas
plasmid
plko
ratio
weight
stabl
clone
select
use
puromycin
growth
medium
use
confer
puromycin
resist
stabl
clone
librari
contain
approxim
fda
approv
drug
druglik
tool
compound
purchas
prestwick
chemic
inc
cell
stabli
express
split
glassbottom
well
plate
matric
spokan
wa
densiti
mediawel
use
multidrop
dispens
titertek
instrument
huntsvil
al
plate
incub
overnight
co
follow
day
chemic
compound
mm
dmso
prestwick
librari
dilut
cultur
media
ad
well
cell
use
biomek
fx
liquid
handler
configur
channel
head
beckman
coulter
san
jose
ca
produc
dilut
overal
final
compound
concentr
per
well
cell
incub
compound
hr
prior
fixat
pb
contain
paraformaldehyd
fluoresc
nuclear
stain
plate
store
analysi
imagexpress
ultra
high
throughput
imag
system
molecular
devic
sunnyval
ca
equip
nm
argon
laser
imag
gfp
nm
krypton
laser
imag
imag
data
verifi
visual
inspect
factor
calcul
robust
assay
intern
assess
surfac
biotin
label
method
cell
grown
confluenc
cm
plate
wash
twice
pb
contain
mm
hepe
incub
hr
ml
mgml
sulfonhsssbiotin
pierc
rockford
il
wash
three
time
cold
pb
contain
trishcl
assess
intern
cell
incub
hr
cultur
medium
without
niclosamid
return
incub
min
twice
fresh
glutathion
cleavag
solut
mm
reduc
lglutathion
mm
nacl
mm
edta
bsa
n
naoh
order
remov
biotin
remain
cell
surfac
cell
wash
cold
pb
three
time
lyse
ripa
buffer
mm
trishcl
ph
mm
nacl
sodium
deoxychol
sd
biotinyl
protein
cell
lysat
pull
neutravidin
bead
pierc
rockford
il
bead
elut
laemmli
sd
load
mm
dithiothreitol
hr
room
temperatur
elut
identifi
use
sdspage
antigfp
antibodi
control
surfacebiotinyl
cell
wash
trishcl
either
directli
lyse
ripa
buffer
assay
total
biotinlabel
immedi
subject
glutathion
cleavag
monitor
effici
biotin
remov
confoc
imag
acquir
zeiss
confoc
microscop
analyz
use
comput
program
metamorph
univers
imag
corpor
describ
measur
number
intern
vesicl
per
cell
cytosol
care
trace
exclud
cell
membran
intern
vesicl
defin
set
threshold
imag
background
intens
number
intern
vesicl
per
cell
count
metamorph
softwar
cell
per
sampl
analyz
obtain
statist
signific
cell
serumstarv
mem
min
incub
conjug
transferrin
tf
togeth
niclosamid
hr
remov
remain
surfac
bound
tf
cell
expos
unlabel
transferrin
mgml
min
room
temperatur
cell
fix
paraformaldehy
imag
confoc
microscop
zeiss
topflash
luciferas
assay
topflash
stabl
cell
seed
grow
mediumwel
plate
confluenc
fifti
microlit
condit
medium
contain
chemic
compound
test
dmso
ad
well
treatment
cell
wash
pb
lyse
mper
solut
pierc
rockford
il
thirti
microlit
cell
lysat
use
measur
luciferas
activ
plate
reader
fluostar
optima
bmg
labtech
chicago
il
assay
cytosol
stabil
express
cell
grown
confluenc
treat
control
condit
medium
condit
medium
supplement
dmso
vari
concentr
niclosamid
hr
treatment
cytosol
fraction
well
cellular
membran
isol
describ
immunoblot
use
antibodi
use
detect
respect
protein
level
cytosol
membran
immunoblot
use
load
control
order
screen
small
molecul
modul
frizzl
receptor
intern
develop
assay
compat
high
throughput
screen
gener
cell
line
stabli
express
cellular
distribut
chimera
initi
assess
confoc
microscopi
local
predominantli
plasma
membran
almost
intern
vesicl
present
cell
stimul
wnt
ligand
fig
treat
condit
medium
cell
show
minim
intern
receptor
fluoresc
fig
wherea
cell
expos
condit
medium
demonstr
moder
amount
intracellular
fluoresc
fig
observ
indic
intern
could
provid
readout
agonistligand
activ
fdaapprov
drug
druglik
compound
prestwick
chemic
librari
screen
concentr
format
primari
screen
reveal
hit
niclosamid
prestwick
produc
much
robust
intern
fig
even
stimul
fig
verifi
result
cell
also
treat
niclosamid
obtain
altern
supplier
sigma
similarli
strong
intern
observ
fig
control
human
egf
receptor
express
plasma
membran
cell
xr
ren
unpublish
data
intern
treat
equival
concentr
niclosamid
fig
primari
screen
identifi
addit
small
molecul
compound
tabl
effect
intern
littl
effect
wnt
signal
assess
topflash
luciferas
report
assay
data
shown
compound
therefor
studi
small
molecul
hit
niclosamid
demonstr
potenti
modul
wnt
signal
see
section
investig
detail
assess
effect
niclosamid
intern
employ
method
independ
complementari
primari
screen
methodolog
use
biotin
label
plasma
membran
receptor
first
cell
surfac
biotinyl
label
cell
surfac
receptor
popul
next
label
cell
incub
allow
receptor
intern
presenc
niclosamid
receptor
intern
assay
biotin
label
protect
glutathion
cleavag
visual
use
antigfp
immunoblot
fig
lane
show
total
biotin
label
cell
surfac
nearli
complet
remov
band
lane
demonstr
receptor
cell
surfac
intern
suscept
glutathion
cleavag
biotin
label
contrast
biotinyl
receptor
expos
niclosamid
permiss
intern
temperatur
fig
lane
produc
strong
immunoblot
signal
compar
cell
treat
niclosamid
fig
lane
indic
niclosamideintern
receptor
origin
plasma
membran
determin
timecours
intern
receptor
measur
accumul
cytosol
punctavesicl
hr
fig
fig
graphic
represent
intern
time
cours
show
hr
niclosamideinduc
intern
fig
show
dosedepend
hr
time
point
intern
presenc
increas
concentr
niclosamid
niclosamid
concentr
observ
signific
increas
number
intern
receptor
suggest
potenc
niclosamid
induc
intern
low
micromolar
rang
fig
mani
class
membran
receptor
intern
clathrin
coat
pit
particular
receptor
prototyp
clathrindepend
intern
g
proteincoupl
receptor
transferrin
welldocu
standard
clathrinmedi
intern
gener
demonstr
intern
coloc
either
adrenerg
receptorrfp
transferrin
intracellular
vesicl
would
indic
also
intern
similar
manner
fig
show
cell
express
ar
receptor
prior
activ
condit
two
receptor
intracellularli
coloc
exposur
isoproterenol
niclosamid
hr
fig
result
multipl
overlap
intracellular
distribut
receptor
moreov
intern
transferrin
hr
signific
coloc
intern
fig
data
suggest
niclosamideinduc
intern
occur
clathrinco
pit
dishevel
protein
mammalian
cell
intracellular
molecul
transduc
frizzl
signal
assess
effect
niclosamid
wnt
signal
mechan
examin
protein
express
dishevel
cell
stimul
either
control
condit
medium
treatment
niclosamid
hr
result
dramat
reduct
cytosol
protein
fig
half
maxim
reduct
occur
niclosamid
concentr
approxim
fig
endogen
detect
membran
fraction
endogen
detect
use
commerci
antibodi
data
shown
leftcf
transcript
factor
report
topflash
assay
gener
readout
canon
wnt
signal
pathway
assess
effect
niclosamid
wnt
signal
activ
gener
cell
line
stabli
express
leftcf
transcript
factor
report
plasmid
topflash
respond
wnt
mediat
induct
renila
luciferas
plasmid
serv
intern
control
abil
niclosamid
promot
intern
suggest
agonist
partial
agonistlik
behavior
niclosamid
alon
produc
statist
signific
increas
topflash
leftcf
report
signal
fig
upon
stimul
fold
induct
leftcf
report
signal
observ
fig
remark
addit
niclosamid
condit
medium
block
increas
report
signal
observ
alon
fig
indic
niclosamid
inhibit
wntfrizzl
signal
induc
full
agonist
wnt
case
inhibitori
effect
dosedepend
ic
fig
accumul
cytosol
measur
canon
wnt
signal
report
assay
indic
wnt
induc
cytosol
accumul
reduc
presenc
niclosamid
figur
demonstr
niclosamid
prevent
cytosol
stabil
compar
lane
upper
panel
cytosol
howev
membranebound
level
rel
unchang
fig
bottom
panel
membran
indic
reduct
signal
pool
due
loss
express
potenc
niclosamid
inhibit
wntmediat
stabil
determin
dose
depend
present
immunoblot
fig
half
maxim
inhibit
signal
occur
niclosamid
concentr
approxim
summari
data
indic
niclosamid
promot
intern
regul
express
protein
inhibit
leftcf
topflash
report
activ
stabil
therefor
niclosamid
function
inhibitor
wnt
signal
report
niclosamid
salicylanilid
deriv
salicyl
acid
common
therapeut
usag
treatment
intestin
tapeworm
infect
niclosamid
also
demonstr
activ
mollusk
exampl
niclosamid
wide
use
china
molluscosid
attempt
erad
schistosom
contain
snail
recent
niclosamid
found
effect
low
micromolar
concentr
prevent
synthesi
corona
viru
protein
tissu
cultur
model
sever
acut
respiratori
syndrom
sar
mechan
action
instanc
well
defin
niclosamid
interact
dna
believ
niclosamid
uncoupl
oxid
phosphoryl
tapeworm
current
radiolabel
wnt
bind
assay
frizzl
prevent
direct
test
niclosamid
abil
compet
bind
site
howev
data
indic
niclosamid
use
tool
compound
modul
wntfrizzl
function
studi
cancer
regener
molecular
level
niclosamid
proven
safe
human
administ
short
durat
explor
clinic
util
niclosamid
possibl
cancer
treatment
abil
block
wnt
direct
transcript
activ
weigh
biolog
effect
howev
case
refractori
cancer
benefit
may
worth
risk
altern
structur
modif
deriv
niclosamid
may
eventu
provid
safe
effect
drug
therapi
patient
underli
wnt
direct
cancer
stabl
cell
subject
cellsurfac
biotin
label
describ
materi
method
upper
panel
show
immunoblot
ib
biotinlabel
enrich
use
neutravidin
bead
pull
antigfp
antibodi
detect
lower
panel
serv
load
control
ensur
equal
amount
cell
lysat
use
neutravidin
pull
treatment
surfac
biotinyl
glutathion
niclosamid
temperatur
indic
blot
ae
stabl
cell
treat
niclosamid
indic
time
hr
f
intern
assess
count
number
contain
vesicl
cytosol
use
comput
program
metamorph
result
present
graph
given
time
hr
n
cell
hr
n
hr
n
hr
n
hr
n
pair
data
time
hr
analyz
student
ttest
signific
p
fig
respect
number
cell
correspond
individu
dose
n
data
analyz
pair
sampl
use
student
ttest
signific
p
jl
depict
similar
studi
cell
express
expos
transferrin
tf
niclosamid
hr
merg
imag
present
l
arrowhead
indic
coloc
vesicl
ab
cell
stabli
express
topflash
luciferas
report
renilla
luciferas
treat
control
condit
medium
condit
medium
presenc
dmso
vehicl
niclosamid
niclo
inhibitori
effect
stimul
topflash
report
activ
niclosamid
shown
ns
signific
p
p
ttest
ctl
cm
cm
depict
control
condit
medium
respect
b
demonstr
inhibit
depend
niclosamid
concentr
averag
topflash
report
activ
plu
dmso
treatment
set
rel
report
activ
plu
indic
concentr
niclosmid
calcul
plot
cd
niclosamid
inhibit
cytosol
stabil
cell
demonstr
immunoblot
cytosol
serv
load
control
c
show
effect
niclosamid
treatment
wherea
demonstr
inhibitori
effect
occur
rang
niclosamid
